Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;77:565-574

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y. G.
Right arrow Articles by Lipsius, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y. G.
Right arrow Articles by Lipsius, S. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
(Circulation Research. 1995;77:565-574.)
© 1995 American Heart Association, Inc.


Articles

ß-Adrenergic Stimulation Induces Acetylcholine to Activate ATP-Sensitive K+ Current in Cat Atrial Myocytes

Presented in part in abstract form (Biophys J. 1995;68:12).

Yong Gao Wang, Stephen L. Lipsius

From the Department of Physiology, Loyola University of Chicago, Stritch School of Medicine, Maywood, Ill.

Correspondence to Stephen L. Lipsius, PhD, Department of Physiology, Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Our previous work on atrial myocytes suggested that the effect of acetylcholine (ACh) to increase K+ conductance can be potentiated by prior loading of the sarcoplasmic reticulum (SR) with Ca2+. The present study, therefore, sought to determine whether prior exposure to isoproterenol (ISO) potentiates ACh-induced increases in K+ conductance and the underlying mechanisms. A nystatin–perforated patch whole-cell configuration was used to record from cat atrial myocytes. Voltage-clamp ramps (40 mV/s) were used to assess total membrane conductance. The experimental protocol consisted of two consecutive 30-second ACh exposures (ACh1 and ACh2) separated by a 6-minute recovery period in ACh-free solution. In general, experimental interventions, such as exposure to ISO, were imposed during the period between ACh1 and ACh2 to determine their effects on the response to ACh2 in relation to ACh1. Under control conditions, K+ conductances induced by ACh1 and ACh2 were not different from one another with or without activation of L-type Ca2+ current (ICa,L) during the recovery period. When 1 µmol/L ISO plus ICa,L activation was imposed during the recovery period, ACh2 induced a significantly larger increase in K+ conductance than ACh1. The ACh2-induced K+ current potentiated by ISO was time independent and selectively blocked by 10 µmol/L glibenclamide and therefore identified as ATP-sensitive K+ current (IK,ATP). The effect of ISO to induce ACh2-activated IK,ATP was mimicked by 1 µmol/L forskolin or 200 µmol/L 8-(4-chlorophenylthio)-cAMP, but not by 0.5 µmol/L BAY K 8644, and was selectively abolished by (1) 5 µmol/L thapsigargin or 1 µmol/L ryanodine, agents that prevent accumulation of SR Ca2+, (2) inhibition of L-type Ca2+ current (ICa,L) by 1 µmol/L nisoldipine or zero external Ca2+, (3) 50 µmol/L Rp-cAMPs, an inhibitor of cAMP-dependent protein kinase A, or (4) 2 µmol/L propranolol. Atropine (1 µmol/L) abolished all ACh-induced currents. Moreover, ACh2-activated IK,ATP was selectively blocked by 0.2 µmol/L pirenzepine, an M1 muscarinic receptor antagonist, or 0.1 µmol/L calphostin C, a selective inhibitor of protein kinase C. AFDX116 (100 µmol/L), an M2 muscarinic receptor antagonist, blocked the conventional ACh-activated K+ current and revealed ACh2-activated IK,ATP. These results indicate that prior exposure to ISO potentiates ACh-induced increases in K+ current via ACh-activated IK,ATP. ISO acts via ß-adrenergic receptors and cAMP to enhance both Ca2+ influx via ICa,L and SR Ca2+ uptake. By loading SR Ca2+, ISO facilitates ACh-induced stimulation of the M1 receptor/phosphoinositol signaling pathway to activate IK,ATP. These findings suggest that prior ß-adrenergic stimulation accentuates subsequent cholinergic inhibition of atrial function via ACh-induced activation of ATP-sensitive K+ channels.


Key Words: perforated patch • muscarinic receptors • cAMP • forskolin • phosphoinositol • calcium


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
ACh affects cardiac function through a variety of signal transduction pathways. Thus, ACh acts via muscarinic receptors coupled to PTX-sensitive G proteins to inhibit adenylate cyclase activity1 and thereby inhibit cardiac responses mediated by cAMP. This mechanism contributes to the accentuated inhibitory effects of ACh observed in the presence of ß-adrenergic receptor stimulation, ie, accentuated antagonism.2 3 ACh can also act via muscarinic receptors and pertussis toxin–sensitive G proteins to directly activate K+ channel currents (IK,ACh).4 5 This mechanism is membrane-delimited and therefore not mediated via second messengers. Recent reports,6 7 8 including our own,9 10 indicate that ACh also can activate cardiac IK,ATP. However, the mechanisms underlying cholinergic regulation of IK,ATP are not well understood. Work on ventricular cell membrane patches suggests that ACh may activate IK,ATP via G proteins that lower the sensitivity of ATP-sensitive K+ channels to inhibition by ATP.8 Our previous studies in atrial myocytes indicate that ACh activates IK,ATP via second messengers generated by the PI signaling pathway.10 Moreover, these studies suggest that the ability of ACh to activate IK,ATP depended on prior loading of SR Ca2+ induced by an initial ACh exposure. This latter finding has led to the present hypothesis that other agents that raise SR Ca2+ can stimulate ACh-induced activation of IK,ATP. In the present study, therefore, we sought to determine whether prior ß-adrenergic stimulation by ISO can induce ACh to activate IK,ATP.

The response of atrial myocytes to ISO can be altered by the ruptured-patch recording method, presumably because of cell dialysis.11 In the present study, therefore, we used a nystatin–perforated patch12 whole-cell recording method to minimize alterations in the intracellular milieu and thereby preserve intracellular signaling processes. The present experiments indicate that prior exposure to ISO induces ACh to activate a GLIB-sensitive K+ current, presumably IK,ATP. The effect of ISO to potentiate ACh-induced increases in K+ conductance is a novel mechanism that may contribute to accentuated cholinergic antagonism of atrial function.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Details of the isolation and recording methods have been published previously.13 Briefly, adult cats of either sex were anesthetized with sodium pentobarbital (70 mg/kg IP). Hearts were mounted and perfused via a Langendorff apparatus. The initial perfusion was a bicarbonate-buffered Tyrode's solution for {approx}5 minutes followed by a 5-minute perfusion with a nominally Ca2+-free Tyrode's solution and then a 30- to 40-minute perfusion with low (36 µmol/L) Ca2+ Tyrode's solution containing 0.06% collagenase (Worthington Biochemical, type II). After collagenase perfusion, both atria were cut into small pieces and agitated in fresh collagenase and 0.01% protease. Experiments were performed on either right or left atrial cells, with no discernible differences.

Cells used for study were transferred to a small (0.3-mL) tissue bath on the stage of an inverted microscope (Nikon Diaphot) and superfused with a modified Tyrode's solution containing (in mmol/L) NaCl 137, KCl 5.4, MgCl2 1.0, CaCl2 2.5, HEPES 5, and glucose 11 and titrated with NaOH to a pH of 7.4. Solutions were perfused by gravity at {approx}5 mL/min, and experiments were performed at 35±1°C. Cells studied were isolated on the same morning as each experiment, and those selected for study were elongated and quiescent. Voltage and ionic currents were recorded by using a nystatin–perforated patch12 whole-cell recording method.14 This method minimizes dialysis of intracellular constituents with the internal pipette solution. Nystatin was dissolved in dimethyl sulfoxide at a concentration of 50 mg/mL and then added to the internal pipette solution to yield a final nystatin concentration of 150 µg/mL. The internal pipette solution contained (in mmol/L) potassium glutamate 100, KCl 40, MgCl2 1.0, Na2-ATP 4, EGTA 0.5, and HEPES 5 and was titrated with KOH to a pH of 7.2. Pipettes had inner diameters of 1 to 1.5 µm and, when filled with internal solution, had resistances of 2 to 3 M{Omega}. Once a gigaseal was formed, access resistance decreased to as low as 15 M{Omega} after {approx}5 to 10 minutes.

Our standard experimental protocol involved an initial 30-second ACh exposure (ACh1) followed by a 6-minute recovery period in ACh-free solution and then a second 30-second ACh exposure (ACh2) (see Fig 1Down). In most experiments, ICa,L was activated by depolarizing voltage-clamp pulses imposed during the recovery period between ACh1 and ACh2. In general, experimental interventions such as exposure to ISO, forskolin, and BAY K 8644 were also imposed during the 6-minute recovery period, after ACh1 and before ACh2, unless stated otherwise. In this way, we determined the effect of each experimental intervention on ACh-induced K+ conductances by comparing the response to ACh2 in relation to ACh1. Voltage-clamp ramps (40 mV/s) between -130 and +30 mV were imposed during and after each ACh exposure to assess changes in total membrane conductance. Voltage ramps were delivered during the administering of ACh at the peak increase in ACh-induced K+ conductance, ie, within {approx}1 second. In some experiments, steady state I-V relations were generated by clamping from a holding potential of -40 mV to more positive and negative voltages for 2 seconds in 10-mV increments. Steady state currents were measured at the end of each clamp step. In these experiments, external solutions contained 1 µmol/L verapamil to block ICa,L and 1 mmol/L 4-aminopyridine to block transient outward current, respectively. Activation of ICa,L was elicited by voltage-clamp steps from a holding potential of -40 to 0 mV for 200 milliseconds at 0.5 Hz. Current densities (pA/pF) were determined by normalizing currents to total cell capacitance.15



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. I-V relations of original K+ currents elicited by two consecutive ACh exposures separated by a 6-minute recovery period. A, ICa,L was activated by depolarizing pulses during the recovery period between ACh1 and ACh2. ACh1 and ACh2 elicited similar increases in K+ current. B, ISO (1 µmol/L) plus ICa,L activation were imposed during the recovery period. ACh2 elicited a larger increase in K+ current than did ACh1 at voltages positive and negative to the reversal potential. Inset, ISO increased basal ICa,L amplitude (328%) and slowed inactivation. c,w indicates background currents recorded during the control period (c) shortly before ACh1 and during the recovery period (w) shortly before ACh2.

A single suction pipette recorded voltage (bridge mode) or ionic currents (discontinuous voltage-clamp mode) by use of an Axoclamp 2A amplifier (Axon Instruments, Inc). In the voltage-clamp mode, the sample rate was {approx}10 to 12 kHz. A second scope was used to monitor the duty cycle to ensure complete settling of the voltage transient between samples. Computer software (PCLAMP, Axon Instruments, Inc) was used to deliver voltage protocols and to acquire and analyze data. All signals were digitally recorded on VCR tape.

Drugs included ACh (Sigma Chemical Co), ISO (Sigma), forskolin (Sigma), Rp-cAMPs (LC Laboratories), ryanodine (Progressive Agri-Systems, Inc), 8-CPT-cAMP (Sigma), BAY K 8644 (a generous gift from Miles, Inc), thapsigargin (Sigma), atropine (Sigma), AFDX116 (a generous gift from Boehringer Ingelheim), calphostin C (Kamiya Biomedical Co), pirenzepine (Sigma), propranolol (Sigma), and GLIB (Sigma). Statistical significance of paired and unpaired data was determined by Student's t test and at P<.05. Data are expressed as mean±SEM.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Effect of ISO on IK,ACh
Fig 1AUp shows original currents elicited by voltage-clamp ramps during the two consecutive ACh exposures (ACh1 and ACh2) that were separated by a 6-minute recovery period. ICa,L was activated by depolarizing pulses every 2 seconds during the recovery period between ACh1 and ACh2 (not shown). The I-V relation shows that ACh1 elicited an increase in membrane conductance typical of IK,ACh, ie, a reversal potential close to the K+ equilibrium potential, and inward rectification at positive voltages. ACh2 elicited essentially the same increase in K+ current as did ACh1; ie, ACh1- and ACh2-induced currents were superimposed. In a total of four cells, there were no significant differences between currents induced by ACh1 and ACh2. Similar results were obtained when the same protocol was performed without activation of ICa,L during the recovery period; ie, ACh1- and ACh2-induced currents were superimposed (not shown) (n=4). These findings indicate that an initial 30-second exposure to ACh has no influence on the effect of a second 30-second ACh exposure to increase K+ conductance. Furthermore, the additional Ca2+ influx resulting from activation of basal ICa,L has no influence on the ability of ACh2 to increase K+ conductance. In Fig 1BUp, the same protocol was repeated, including activation of ICa,L, with the addition of 1 µmol/L ISO during the recovery period between ACh1 and ACh2. ISO had no effect on background current (w in Fig 1BUp). As expected, ISO markedly increased peak ICa,L amplitude and slowed inactivation (inset). ISO increased mean peak ICa,L by 220% (n=6). After exposure to ISO and ICa,L activation for 6 minutes, ACh2 induced a markedly larger increase in K+ conductance than ACh1 at voltages both positive and negative to the reversal potential. In a total of 15 cells, after subtraction of control background currents, ACh1- and ACh2-induced K+ currents elicited at -130 mV were 10.8±1.0 and 14.7±1.2 pA/pF, respectively (P<.005), and those elicited at +30 mV were 11.7±1.0 and 15.2±1.5 pA/pF, respectively (P<.005). The percent changes between ACh1- and ACh2-induced K+ currents for this series of experiments and the subsequent experiments described below are summarized in the TableDown. The present findings indicate that ISO potentiates ACh2-induced increases in K+ conductance. The purpose of the present study was to determine the nature of the ACh-induced K+ current potentiated by ISO and the underlying mechanisms responsible for its activation.


View this table:
[in this window]
[in a new window]
 
Table 1. Percent Changes in K+ Currents Induced by ACh2 in Relation to ACh1

Effect of GLIB
Our previous study10 indicates that under appropriate conditions ACh can activate two separate K+ currents: IK,ACh and a K+ current that is inhibited by GLIB, a specific blocker of IK,ATP in cardiac muscle.16 17 In Fig 2ADown, we determined whether the ACh2-induced K+ current potentiated by ISO was selectively blocked by 10 µmol/L GLIB. GLIB was administered throughout the experiment, and 1 µmol/L ISO and ICa,L activation were imposed during the recovery period. Although GLIB had no effect on background K+ currents, it selectively blocked the ACh2-induced K+ current potentiated by ISO. In the four cells studied, the ACh1- and ACh2-induced K+ currents at -130 mV were 11.3±1.7 and 11.6±1.8 pA/pF, respectively, and those at +30 mV were 19.5±3.9 and 19.8±3.9 pA/pF, respectively. These results suggest that the ACh2-induced K+ current potentiated by ISO is IK,ATP.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Effect of GLIB on ACh2-induced K+ currents potentiated by ISO. A, I-V relation of original K+ currents elicited by ACh1 and ACh2 separated by a 6-minute recovery period. ICa,L activation and 1 µmol/L ISO were imposed during the recovery period. GLIB (10 µmol/L) was administered throughout the experiment. GLIB selectively abolished the ACh2-induced K+ current potentiated by ISO. B, Mean I-V relations of ACh2-induced K+ current potentiated by ISO ({circ}) and GLIB-sensitive K+ current ({bullet}) (n=4). c,w indicates background currents recorded during the control period (c) shortly before ACh1 and during the recovery period (w) shortly before ACh2.

In Fig 2BUp, we compared the mean I-V relations for the ACh2-induced K+ current potentiated by ISO ({circ}) and the GLIB-sensitive K+ current ({bullet}). The I-V relation of the potentiated ACh2-induced K+ current was determined from the mean data presented in Fig 1BUp. Background currents were subtracted from the respective ACh-induced K+ currents, and then the currents induced by ACh1 were subtracted from those induced by ACh2. The GLIB-sensitive K+ current was determined by using the mean data from two different groups of cells. The GLIB-insensitive K+ current, as shown in Fig 2AUp, was subtracted from the total K+ current induced by ACh2 under control conditions, as shown in Fig 1BUp. It is apparent that both I-V relations exhibit similar features. Both currents exhibited a linear conductance at voltages negative to {approx}-50 mV and inwardly rectified at more positive voltages. Moreover, the reversal potential and slope conductance of the potentiated ACh2-induced K+ current (-83±2 mV, 133±17 pS/pF) were not statistically different from those of the GLIB-sensitive K+ current (-79±1 mV, 110±27 pS/pF) (n=4).

In Fig 3Down, we further characterized the ACh-activated GLIB-sensitive K+ current by determining its steady state I-V relation by use of voltage-clamp steps. In these experiments, cells were exposed to 1 µmol/L ISO plus ICa,L activation for 6 minutes, followed by exposure to 10 µmol/L ACh. Clamp steps between -120 and +20 mV were imposed during continuous exposure to ACh in the absence and then presence of 10 µmol/L GLIB. Fig 3ADown shows original ACh-activated GLIB-sensitive K+ currents determined by subtracting currents obtained in the presence from those in the absence of GLIB. As shown, the currents are time independent and inwardly rectifying and are relatively noisy at positive voltages. These features are consistent with those of IK,ATP.18 In Fig 3BDown, the steady state I-V relation shows a reversal potential of -82 mV and a slope conductance of 151 pS/pF. In a total of three cells, the mean slope conductance was 147±6 pS/pF, and the reversal potential was 80±1 mV. These values are similar to those of the ACh-activated GLIB-sensitive K+ currents obtained with voltage ramps (Fig 2BUp).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Steady state ACh-activated GLIB-sensitive K+ currents. A, An atrial cell was exposed to 1 µmol/L ISO for 6 minutes, followed by exposure to 10 µmol/L ACh. During ACh, voltage-clamp steps were imposed from a holding potential of -40 mV to voltages between +20 and -120 mV for 2 seconds in the absence and presence of 10 µmol/L GLIB. External solutions contained 1 µmol/L verapamil and 1 mmol/L 4-aminopyridine. B, Steady-state I-V relation of ACh-activated GLIB-sensitive K+ currents.

In four additional cells, we used DNP, a metabolic inhibitor that lowers intracellular ATP levels and thereby activates IK,ATP in cardiac muscle.19 Voltage-clamp ramps were used to assess K+ conductances. DNP (100 µmol/L) induced an increase in current at voltages both negative and positive to the reversal potential that was blocked by 10 µmol/L GLIB (not shown). The mean slope conductance (148±15 pS/pF) and reversal potential (82±1 mV) of the DNP-induced K+ currents were not statistically different from those of the ACh2-induced K+ currents potentiated by ISO (see Fig 2BUp).

Effects of ISO Are Mediated via cAMP
The next several experiments were designed to determine the possible mechanisms responsible for the effects of ISO to elicit ACh-activated IK,ATP. If the effects of ISO are mediated, as expected, via stimulation of cAMP, then forskolin should mimic the effects of ISO. In Fig 4ADown, the experimental protocol was repeated with 1 µmol/L forskolin plus ICa,L activation imposed during the recovery period. Forskolin increased mean basal ICa,L amplitude by 260% (n=3), which was comparable to that induced by ISO (not shown). Like ISO, forskolin had no effect on background current. After the 6-minute exposure to forskolin, ACh2 induced a larger increase in K+ conductance than ACh1 at voltages both positive and negative to the reversal potential. In the five cells studied, after subtraction of background currents, ACh1- and ACh2-induced K+ currents elicited at -130 mV were 18.7±4.0 and 23.3±3.4 pA/pF, respectively (P<.02), and those at +30 were 20.4±2.5 and 25.4±2.4 pA/pF, respectively (P<.03). These values are comparable to those elicited by ISO (Fig 1BUp and TableUp) and strongly suggest that the effects of ISO are mediated via cAMP.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 4. Effects of forskolin and BAY K 8644. A, Forskolin (1 µmol/L) plus ICa,L activation were imposed during the recovery period. Forskolin mimicked the effects of ISO. B, BAY K 8644 (0.5 µmol/L) plus ICa,L activation were imposed during the recovery period. ACh2 elicited only a modestly larger increase in K+ current than did ACh1. c,w indicates background currents recorded during the control period (c) shortly before ACh1 and during the recovery period (w) shortly before ACh2.

If cAMP mediates the effects of ISO, then directly increasing intracellular cAMP should also mimic the effects of ISO. Therefore, we determined whether 8-CPT-cAMP, a membrane-permeable analogue of cAMP that directly activates PKA, could potentiate ACh2-induced increases in K+ current. ICa,L activation and exposure to 200 µmol/L 8-CPT-cAMP were imposed during the period between ACh1 and ACh2. 8-CPT-cAMP increased mean basal ICa,L by 203% (n=5), which was comparable to the effects of ISO or forskolin. Under these conditions, ACh2 elicited a significantly larger increase in K+ current than ACh1 at voltages both positive and negative to the reversal potential. In a total of five cells, after subtraction of background currents, ACh1- and ACh2-induced K+ currents elicited at -130 mV were 13.0±1.5 and 17.2±2.2 pA/pF, respectively (P<.01), and those elicited at +30 were 13.4±1.1 and 17.2±1.6 pA/pF, respectively (P<.02).

One possible explanation of these findings is that ISO, forskolin, and 8-CPT-cAMP each stimulate Ca2+ influx via ICa,L, and the additional intracellular Ca2+ somehow stimulates ACh2 to activate IK,ATP. If this hypothesis is correct, then stimulation of ICa,L by BAY K 8644 should also mimic the effects of each of these agents. BAY K 8644 is a direct L-type Ca2+ channel agonist20 that does not act via cAMP. In Fig 4BUp, 0.5 µmol/L BAY K 8644 and ICa,L activation were imposed during the recovery period. Although BAY K 8644 increased mean basal ICa,L by +197% (not shown), ACh2-induced activation of K+ current was only modestly potentiated compared with ACh1. In the three cells studied, K+ currents induced by ACh1 and ACh2 at -130 mV were 12.1±1.4 and 14.0±1.8 pA/pF, respectively, and those at +30 mV were 13.2±2.0 and 15.0±2.5 pA/pF, respectively. These findings suggest that enhanced Ca2+ influx via ICa,L alone cannot account for the effects of ISO to induce ACh-activated IK,ATP.

Contribution of ICa,L
In the experiments shown in Fig 5ADown, we assessed the contribution made by ICa,L to the effects of ISO. ACh was administered three consecutive times for 30 seconds each. ISO was administered during both 6-minute recovery periods between each ACh exposure. ICa,L activation, however, was imposed only during the second recovery period between ACh2 and ACh3. After the initial exposure to ISO alone, ACh2 elicited an increase in K+ conductance that was modestly larger than ACh1 at voltages negative and positive to the reversal potential. In a total of eight cells, ISO alone potentiated ACh2-induced compared with ACh1-induced K+ current by +12.5±5.5% (-130 mV) and +13.0±2.1% (+30 mV). When ICa,L was activated in conjunction with exposure to ISO during the second recovery period, the ACh3-induced increase in K+ conductance was markedly potentiated. Compared with the response to ACh2, ACh3 elicited a further increase in K+ current of +55.7±8.3% (-130 mV) and +31.5±11.5% (+30 mV) (n=5). When compared with ACh1, ACh3 increased K+ current by +76.5±9.3% (-130 mV) and +49.1±15.7% (+30 mV) (n=5). Clearly, the ability of ISO to potentiate ACh-induced increases in K+ conductance is significantly enhanced by ICa,L activation.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 5. Contribution of ICa,L. A, Effect of ISO alone and ISO plus ICa,L activation on ACh-induced K+ currents. I-V relation of original K+ currents showing the response to three consecutive exposures to 1 µmol/L ACh separated by two 6-minute recovery periods. ISO (1 µmol/L) was administered during both recovery periods, and ICa,L activation was imposed only during the second recovery period. B, Effect of 1 µmol/L nisoldipine on ACh2-induced K+ currents potentiated by ISO. I-V relation of original K+ currents elicited by ACh1 and ACh2 separated by a 6-minute recovery period is shown. ICa,L activation and 1 µmol/L ISO were imposed during the recovery period. Nisoldipine was administered throughout the experiment. Nisoldipine selectively abolished the ACh2-induced K+ current potentiated by ISO. c,w indicates background currents recorded during the control period (c) shortly before ACh1 and during the recovery period (w) shortly before ACh2 (and ACh3 in panel A).

Another important way of assessing the role of ICa,L in the effects of ISO is to repeat the standard protocol in the presence of nisoldipine, a selective blocker of ICa,L. Nisoldipine (1 µmol/L) blocked all inward current via ICa,L stimulated during the recovery period (not shown). The original records in Fig 5BUp show that in the presence of nisoldipine, ACh1 and ACh2 induced a similar increase in K+ current; ie, ACh2-activated IK,ATP was selectively abolished by blocking ICa,L. In a total of four cells, there were no differences between currents induced by ACh1 and ACh2 in the presence of nisoldipine. In another series of experiments, we determined the effect of omitting Ca2+ from the external solution throughout the experiment (data not shown). Removing external Ca2+ also abolished inward current via ICa,L. Without external Ca2+, ACh1 and ACh2 elicited increases in K+ current that were not significantly different from one another at voltages positive and negative to the reversal potential (n=5). These results indicate that blocking Ca2+ influx via ICa,L selectively inhibits ISO-induced ACh2-activated IK,ATP. Moreover, these findings suggest that although Ca2+ influx via ICa,L alone is not sufficient, it is essential for ISO to induce ACh-activated IK,ATP.

Accumulation of SR Ca2+
Clearly, the present experiments indicate that the effects of ISO are mediated by cAMP. In addition to stimulating ICa,L amplitude, cAMP enhances SR Ca2+ uptake. Therefore, in two series of experiments we tested either thapsigargin, an inhibitor of SR Ca2+ uptake,21 or ryanodine, an alkaloid that opens SR Ca2+ release channels22 and prevents accumulation of SR Ca2+. Each drug was administered from the beginning of its respective experiment, ie, throughout both ACh1 and ACh2. As usual, ISO and ICa,L activation were imposed during the period between ACh1 and ACh2. In the presence of 5 µmol/L thapsigargin, K+ currents induced by ACh1 and ACh2 at -130 mV were 14.2±1.4 and 15.2±1.3 pA/pF, respectively, and those at +30 mV were 15.8±1.8 and 15.1±1.5 pA/pF, respectively (n=5) (see TableUp). In the presence of 1 µmol/L ryanodine, K+ currents induced by ACh1 and ACh2 at -130 mV were 13.6±1.5 and 14.1±1.5 pA/pF, respectively, and those at +30 mV were 16.4±3.5 and 15.2±2.4 pA/pF, respectively (n=4) (see TableUp). These results indicate that by inhibiting the accumulation of SR Ca2+, these agents selectively abolished the effect of ISO to potentiate ACh2-induced K+ current. It is important to note that in the presence of either thapsigargin or ryanodine, ISO elicited a typical increase in ICa,L amplitude (not shown). In another series of experiments, we tested the effects of Rp-cAMPs, a specific inhibitor of cAMP-dependent PKA.23 Rp-cAMPs was administered throughout both ACh1 and ACh2. In the presence of 50 µmol/L Rp-cAMPs, ACh1- and ACh2-induced K+ currents at -130 mV were 12.3±1.6 and 12.9±1.6 pA/pF, respectively, and those at +30 mV were 16.2±2.2 and 15.7±2.4 pA/pF, respectively (n=5). These results indicate that inhibition of cAMP-dependent PKA selectively abolished the ACh2-induced increase in K+ current potentiated by ISO. Although Rp-cAMPs also prevented ISO-induced stimulation of ICa,L (not shown), these experiments collectively suggest that the conditioning effect of ISO requires cAMP-mediated stimulation of SR Ca2+ uptake and accumulation.

ß-Adrenergic and Muscarinic Receptor Subtypes
In the next few experiments, we examined the surface receptors mediating the effects of ISO and ACh. As shown in Fig 6ADown, 1 µmol/L ACh was administered three consecutive times separated by two 6-minute recovery periods. ISO (1 µmol/L) and ICa,L activation were imposed during the recovery periods between each ACh exposure. Propranolol (2 µmol/L) was administered after ACh2, throughout the second recovery period, and during ACh3. As shown, ACh1 elicited a typical increase in K+ conductance. After exposure to ISO plus ICa,L activation, ACh2 also elicited a typical potentiated increase in K+ conductance compared with ACh1. In the presence of propranolol, the response to ACh3 was similar to that of ACh1; ie, propranolol selectively blocked ACh3-activated IK,ATP. In the four cells studied, ACh1 and ACh2 elicited an increase in K+ current at -130 mV of 6.3±1.8 and 8.7±2.3 pA/pF, respectively (P<.5), and at +30 mV the currents were 9.1±1.8 and 12.0±2.1 pA/pF, respectively (P<.01). There were no significant differences, however, between ACh1- and ACh3-induced K+ currents. These results indicate that the effect of ISO to elicit ACh-activated IK,ATP is mediated via ß-adrenergic receptors.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. The role of ß-adrenergic and muscarinic receptors. A, Original current records showing the effect of ß-adrenergic receptor block by propranolol. Propranolol (2 µmol/L) was administered during the second recovery period and during ACh3. ACh2 induced a typical potentiated increase in K+ current compared with ACh1. Propranolol selectively abolished the potentiated K+ current during exposure to ACh3. The responses to ACh3 and ACh1 were not different. B, Original current records showing the effect of 0.2 µmol/L pirenzepine. Pirenzepine was administered throughout the experiment. Pirenzepine selectively abolished the ACh2-induced K+ current potentiated by ISO. C, Original current records showing the effect of AFDX116. AFDX116 (100 µmol/L) was administered after ACh1 and during ACh2. ACh2 induced a smaller, rather than larger, increase in K+ current compared with ACh1. In each series of experiments, ISO (1 µmol/L) and ICa,L activation were imposed during the recovery period. c,w indicates background currents recorded during the control period (c) shortly before ACh1 and during the recovery period (w) shortly before ACh2 (and ACh3 in panel A).

To determine the receptors mediating the effects of ACh, we repeated the standard protocol of ISO and ICa,L activation in the presence of 1 µmol/L atropine. Atropine blocked all ACh-induced changes in current (not shown) (n=2). Although these results indicate that ACh is acting via muscarinic receptors, they do not distinguish among multiple subtypes of muscarinic receptors.24 Our previous work indicated that ACh can act via M2 muscarinic receptors to activate IK,ACh and via M1 muscarinic receptors to activate IK,ATP.10 Therefore, as shown in Fig 6BUp, we used pirenzepine, an M1 receptor antagonist, to determine whether ACh was acting via M1 receptors to elicit the potentiated K+ current. Pirenzepine (0.2 µmol/L) was administered throughout both ACh1 and ACh2. ACh1 elicited a typical increase in K+ current. After exposure to ISO plus ICa,L activation, ACh2 failed to elicit the potentiated increase in K+ current. In the five cells studied, the ACh1- and ACh2-induced K+ currents at -130 mV were 13.5±3.5 and 11.5±3.4 pA/pF, respectively, and those at +30 mV were 19.6±2.3 and 15.5±0.8 pA/pF, respectively. Values at each voltage were not significantly different from one another. These results suggest that after exposure to ISO, ACh2 is acting via M1 receptors to activate IK,ATP.

If ACh2 is acting via M2 and M1 receptors to activate IK,ACh and IK,ATP, respectively, then blocking M2 receptors should allow selective ACh2-induced activation of IK,ATP. As shown in Fig 6CUp, the standard protocol was performed with ISO plus ICa,L activation imposed during the recovery period. AFDX116 (100 µmol/L), a selective M2 antagonist,25 was administered during the recovery period and during ACh2. ACh1 elicited a typical increase in K+ current. In the presence of AFDX116, however, ACh2 elicited a smaller, rather than larger, increase in K+ conductance than ACh1 at voltages both positive and negative to the reversal potential. In addition, the smaller current induced by ACh2 reversed at {approx}-80 mV and inwardly rectified at positive voltages. In the five cells studied, ACh1- and ACh2-induced K+ currents at -130 mV were 8.3±1.5 and 2.1±0.5 pA/pF, respectively (P<.005), and those at +30 mV were 10.0±1.8 and 2.8±0.3 pA/pF, respectively (P<.01). The AFDX116-insensitive current induced by ACh2 was {approx}75% smaller than the ACh1-induced K+ current (see TableUp). In four additional cells, we repeated the same protocol with 100 µmol/L AFDX116 administered throughout both ACh1 and ACh2. Under these conditions, ACh1 failed to elicit any change in current, and ACh2 elicited a small current with features similar to those described in the preceding experiments.

To determine whether the AFDX116-insensitive current was inhibited by GLIB, we performed our standard protocol of exposure to ISO and ICa,L activation during the recovery period and then added 100 µmol/L AFDX116 plus 10 µmol/L GLIB to the external solution immediately after the administration of ACh1 and during the recovery period and ACh2 administration (not shown). Under these conditions, ACh2 failed to activate any significant increase in current. At -130 mV, ACh1 and ACh2 elicited an increase in K+ current of 11.5±0.9 and 0.5±0.2 pA/pF, respectively, and at +30 mV, the currents were 16.2±1.8 and 1.0±0.4 pA/pF, respectively (see TableUp). Taken together, these experiments indicate that after exposure to ISO, ACh is acting via M1 muscarinic receptors to activate IK,ATP.

Role of PKC
M1 muscarinic receptors are coupled to PI hydrolysis,26 the production of DAG, and stimulation of PKC. Therefore, we determined whether calphostin C, a selective PKC antagonist,27 could inhibit ACh2-induced activation of IK,ATP. ISO (1 µmol/L) plus ICa,L activation were imposed during the recovery period, and calphostin C (0.1 µmol/L) was administered after ACh1, during the recovery period, and during ACh2. In the three cells studied, ACh1- and ACh2-induced increases in K+ current at -130 mV were 11.9±1.6 and 12.0±1.5 pA/pF, respectively, and at +30 mV, they were 15.8±3.2 and 15.9±2.9 pA/pF, respectively (see TableUp). Values measured at either voltage were not statistically different. These results indicate that inhibition of PKC selectively abolished ACh2-activated IK,ATP and support the idea that ACh is acting via the PI signaling pathway.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The main finding of the present work is that by elevating SR Ca2+, ISO conditions atrial cells so that a subsequent exposure to ACh elicits a potentiated increase in K+ conductance due to activation of IK,ATP. The hypothesis underlying the present experiments was based on our previous studies showing that an initial prolonged exposure to ACh conditioned atrial cells by raising SR Ca2+ and thereby potentiated the response to a subsequent ACh exposure.9 10 For ACh to condition the cell, the duration of the initial ACh exposure had to be at least 2 minutes.9 In the present study, atrial cells were exposed to ACh for only 30 seconds, to avoid the conditioning effects of an initial ACh exposure on subsequent ACh-induced increases in K+ conductance. Even when Ca2+ influx was increased by activation of ICa,L during the period between two ACh exposures, the responses to ACh1 and ACh2 were not different (Fig 1AUp). However, the addition of ISO plus ICa,L activation during the recovery period potentiated the increase in K+ current induced by ACh2. Several of the present findings identify the ACh2-induced K+ current potentiated by ISO as IK,ATP. Thus, the current was selectively abolished by GLIB, a selective blocker of IK,ATP in cardiac muscle.16 17 Voltage-clamp steps imposed during exposure to ACh revealed time-independent GLIB-sensitive K+ currents that exhibited a steady state I-V relation characteristic of IK,ATP.18 Moreover, metabolic inhibition by DNP elicited a GLIB-sensitive K+ current that exhibited a reversal potential and slope conductance similar to the ACh2-induced K+ current potentiated by ISO. If one assumes that DNP activated most, if not all, of the available ATP-sensitive K+ channels, the fact that the slope conductances of the DNP- and ACh-activated IK,ATP are similar suggests that ACh also may be activating the majority of available ATP-sensitive K+ channels. It is worth noting that the whole-cell slope conductance (normalized for cell capacitance) of DNP-induced IK,ATP in cat atrial myocytes is {approx}2.5 times smaller than that in cat ventricular myocytes (authors' unpublished data, 1994). Assuming that the open probability of the ATP-sensitive K+ channels activated by DNP is similar in both tissues, these findings suggest that the density of ATP-sensitive K+ channels in atrial muscle is significantly lower than in ventricular muscle.

The present findings indicate that the effects of ISO to potentiate ACh-induced increases in K+ current are mediated via cAMP. Thus, the effects of ISO were (1) mediated via ß-adrenergic receptors, (2) mimicked by forskolin and 8-CPT-cAMP, and (3) abolished by inhibition of cAMP-dependent PKA with Rp-cAMPs. Moreover, ISO acted to potentiate ACh-induced K+ current by stimulating both ICa,L and SR Ca2+ uptake. Thus, even though BAY K 8644 increased ICa,L to about the same extent as ISO, it failed to potentiate ACh-induced K+ conductance to the same extent as ISO. This can be explained by the fact that BAY K 8644 is an L-type Ca2+ channel agonist that does not stimulate cAMP and therefore, unlike ISO, does not stimulate SR Ca2+ uptake. Likewise, thapsigargin or ryanodine selectively abolished the effects of ISO on ACh2-activated IK,ATP by depleting SR Ca2+ without decreasing ISO-induced stimulation of ICa,L. These experiments clearly separate the stimulatory effect of ISO on SR Ca2+ uptake from its effect on ICa,L. In addition, the potentiating effect of ISO was significantly diminished or abolished without concomitant ICa,L activation or when ICa,L was blocked by nisoldipine, respectively. In these experiments, the lack of Ca2+ influx via ICa,L also would be expected to attenuate SR Ca2+ uptake. Taken together, these experiments indicate that exposure to ISO conditions the cell through cAMP-induced stimulation of both Ca2+ influx via ICa,L and SR Ca2+ uptake. In addition, the present results support our previous studies,10 in which we concluded that a prolonged ACh exposure conditions atrial cells by loading SR Ca2+.

The present findings also indicate that ACh-induced increases in K+ conductance are mediated via both M2 and M1 muscarinic receptors; M2 receptors mediate activation of IK,ACh, and M1 receptors mediate activation of IK,ATP. Moreover, the fact that ACh-induced activation of IK,ATP was dependent on PKC activity and that M1 receptors mediate PI hydrolysis26 strongly suggests that after exposure to ISO, ACh is acting via the PI signaling pathway to activate IK,ATP. PKC is thought to mediate various intracellular processes, including regulation of ion channels, via phosphorylation of protein substrates. It seems unlikely that PKC was activated directly by ISO rather than by ACh because {alpha}-adrenergic receptors mediate the PI signaling pathway,28 and in the present study the effects of ISO were selectively abolished by ß-adrenergic receptor block. Moreover, these results are consistent with our previous studies showing that ACh acts via M1 receptors and the PI signaling pathway to activate IK,ATP and via M2 receptors to directly activate IK,ACh.10

How does ISO induce ACh to activate IK,ATP? On the basis of the present findings, it seems reasonable to conclude that elevated SR Ca2+ induced by ISO- and ACh-induced stimulation of the PI signaling pathway may operate in concert to activate IK,ATP. One possible response of stimulating the PI signaling pathway is the production of IP3 and the mobilization of intracellular Ca2+ stores.29 It may be that ACh acts via IP3 to mobilize Ca2+ stores filled by prior exposure to ISO, which in turn activates a Ca2+-dependent PKC to phosphorylate ATP-sensitive K+ channels. Atrial muscle contains a Ca2+-dependent PKC-{alpha} subtype.30 The present findings, however, show that ryanodine selectively abolished ACh-induced activation of IK,ATP. This indicates that the SR Ca2+ stores filled by ISO are mediated via ryanodine receptors and not IP3 receptors.31 In addition, the time course of IP3-induced mobilization of intracellular Ca2+ may be too slow to account for the ACh-induced activation of IK,ATP. Alternatively, loading of SR Ca2+ has been shown to enhance the spontaneous release of SR Ca2+ from single Ca2+-release channels, ie, Ca2+ sparks.32 Moreover, Ca2+ sparks32 and the effects of ISO to induce ACh-activated IK,ATP, as shown in the present study, are both abolished by ryanodine. Spontaneous SR Ca2+ release may increase Ca2+ concentrations at selected subsarcolemmal sites that may facilitate activation of IK,ATP. On the basis of work in ventricular membrane patches,33 it seems unlikely that the effects of elevated Ca2+ would be to alter the sensitivity of ATP-sensitive K+ channels to inhibition by ATP. However, several steps in the PI signaling pathway, such as stimulation of membrane-bound phospholipase C and the hydrolysis of phosphoinositides, are Ca2+-dependent processes.34 Moreover, elevated Ca2+ may stimulate Ca2+-dependent PKC subtypes found in atrial muscle.30

Therefore, we propose the model shown in Fig 7Down. A resting atrial myocyte exhibits relatively low SR Ca2+ levels and therefore little, if any, spontaneous SR Ca2+ release. Under these conditions, an initial brief exposure to ACh primarily acts via M2 receptors to directly activate IK,ACh. Subsequent exposure to ISO stimulates cAMP-dependent PKA activity and thereby enhances Ca2+ influx via ICa,L and SR Ca2+ uptake. Both mechanisms contribute to elevating SR Ca2+ levels. By raising SR Ca2+, ISO enhances spontaneous SR Ca2+ release and thereby raises Ca2+ concentrations in restricted subsarcolemmal spaces. This local Ca2+-enriched environment facilitates the effects of a second ACh exposure to act via M1 receptors and the PI signaling pathway. As a result, ACh2-induced activation of PKC, either Ca2+ dependent or Ca2+ independent, phosphorylates membrane sites to activate IK,ATP. Phosphorylation has been proposed as an element in the activation of IK,ATP.7 35



View larger version (16K):
[in this window]
[in a new window]
 
Figure 7. Schematic diagram of the proposed mechanisms responsible for ISO to induce ACh-activated IK,ATP. ACh1 indicates initial exposure to 10 µmol/L ACh before ISO; ACh2, second exposure to 10 µmol/L ACh after ISO; ISO, 1 µmol/L ISO administered between ACh1 and ACh2; M2, M2 muscarinic receptor; M1, M1 muscarinic receptor; ß, ß-adrenergic receptor; AC, adenylate cyclase; Gp, GTP-binding protein; PLC, phospholipase C; PIP2, phosphatidylinositol 4,5-diphosphate; cAMP/PKA, cAMP-dependent PKA; and SL, sarcolemma.

It is worth noting that the ability of ACh to elicit IK,ATP specifically required an increase in SR Ca2+ rather than simply an increase in cytosolic Ca2+. Thus, the ability of ISO to induce ACh-activated IK,ATP was abolished by agents that specifically deplete SR Ca2+, even though the ISO-induced stimulation of Ca2+ influx via ICa,L was unchanged. Moreover, when Ca2+ influx was increased by activation of basal ICa,L alone or by BAY K 8644, ACh either failed to activate IK,ATP or elicited only a modest activation, respectively. These findings are consistent with our previous studies in which depletion of SR Ca2+ with either caffeine or ryanodine also prevented ACh-induced activation of IK,ATP.10 Therefore, we speculate that the SR may function to distribute Ca2+ to specific subsarcolemmal sites at which Ca2+ can modulate regulation of ATP-sensitive K+ channels via the PI signaling pathway.

In ventricular myocytes, ISO has been shown to augment IK,ATP but only when IK,ATP has been previously activated either by pinacidil,36 a K+ channel opener, or by lowering intracellular ATP.37 In the former study, it was speculated that the effects of ISO were due to cAMP-dependent phosphorylation of the channel. This mechanism does not appear to contribute to the present results, because the effects of ISO to induce ACh-activated IK,ATP were selectively blocked by agents such as thapsigargin or ryanodine, which would not be expected to interfere with ISO-induced stimulation of cAMP. In the latter study, ISO enhanced IK,ATP by metabolically depleting local subsarcolemmal ATP levels via stimulation of adenylate cyclase. This effect of ISO could not be mimicked by direct stimulation of PKA with 8-CPT-cAMP and only occurred when intracellular ATP levels were previously lowered below {approx}1 mmol/L. Several of the present findings make it unlikely that a similar mechanism is responsible for the effects of ISO to induce ACh-activated IK,ATP. Thus, the use of the perforated-patch method precludes the possibility that ATP levels were below 1 mmol/L before exposure to ISO or that ISO could drop ATP concentrations that low. In addition, the effects of ISO were mimicked by direct stimulation of PKA with 8-CPT-cAMP, which would bypass stimulation of adenylate cyclase. Moreover, the fact that ISO never induced a change in background current suggests that ISO did not decrease ATP, either locally or globally, to levels low enough to directly activate the channel. Furthermore, drugs that specifically abolished the effects of ISO to induce ACh-activated IK,ATP, such as ryanodine, would not be expected to influence the ability of ISO to stimulate adenylate cyclase or to lower ATP. It is also worth considering that the intracellular ATP concentration that produces half-maximal inhibition of ATP-sensitive K+ channels is {approx}25 to 100 µmol/L.38 It could be argued that only a fraction of the channels may need to be activated to elicit the currents reported in the present study and therefore may require only a small decrease in intracellular ATP below normal. This idea has been proposed to explain findings that early ischemia produces significant shortening in action potential duration with little change in intracellular ATP concentrations.38 The present results, however, indicate that ACh activates as many ATP-sensitive K+ channels as severe metabolic inhibition induced by DNP, suggesting that ACh is activating a relatively large percentage of the available channels. If this response to ACh is somehow dependent on an ISO-induced depletion of intracellular ATP, it seems likely that it would have to be a relatively large decrease in ATP. This seems unlikely given the considerations discussed above.

In terms of cardiac function, cholinergic inhibition is accentuated by the presence of sympathetic stimulation, ie, accentuated antagonism.2 3 At least part of the underlying mechanism is due to cholinergic inhibition of ß-adrenergic–induced stimulation of adenylate cyclase and cAMP.1 The present results demonstrate a novel mechanism of adrenergic-cholinergic interaction that is unrelated to cholinergic inhibition of cAMP. Thus, ß-adrenergic stimulation of cAMP increases SR Ca2+ levels, which in turn enhances ACh-induced increases in K+ conductance. This mechanism may be important in the normal reciprocal interplay between sympathetic and parasympathetic regulation of atrial function. Thus, prior ß-adrenergic stimulation may directly accentuate subsequent cholinergically mediated hyperpolarization and shortening of the action potential duration. In this way, atrial activity enhanced by sympathetic stimulation is effectively antagonized by enhanced cholinergic inhibition of atrial activity. This mechanism may contribute to the antiarrhythmic effects of vagal nerve activity.39 On the other hand, this mechanism may underlie the effect of sympathetic stimulation to enhance atrial flutter rate or initiate atrial fibrillation by shortening atrial refractoriness mediated by vagal nerve stimulation. Finally, the present findings, as well as our previous studies,10 indicate that loading of SR Ca2+ can potentiate ACh-induced increases in K+ conductance via ACh-activated IK,ATP. This represents a fundamentally new mechanism of cholinergic regulation that has wide implications with respect to the way in which drugs, neurotransmitters, and physiological or pathophysiological states that modulate SR Ca2+ may also modulate ACh-induced activation of ATP-sensitive K+ channels.


*    Selected Abbreviations and Acronyms
 
ACh = acetylcholine
ACh1, ACh2 = two consecutive 30-second ACh exposures
8-CPT-cAMP = 8-(4-chlorophenylthio)-cAMP
DAG = diacylglycerol
DNP = 2,4-dinitrophenol
GLIB = glibenclamide
I-V = current-voltage
ICa,L = L-type Ca2+ current
IK,ACh = ACh-activated K+ current
IK,ATP = ATP-sensitive K+ current
IP3 = inositol 1,4,5-trisphosphate
ISO = isoproterenol
PI = phosphoinositol
PKA = protein kinase A
PKC = protein kinase C
SR = sarcoplasmic reticulum


*    Acknowledgments
 
This study was supported by National Institutes of Health grant HL-27652. We thank C. Rechenmacher for her expert technical assistance.

Received December 27, 1994; accepted May 12, 1995.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Fleming JW, Strawbridge RA, Watanabe AM. Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol. 1987;19:47-61. [Medline] [Order article via Infotrieve]

2. Levy MN. Cardiac sympathetic-parasympathetic interactions. Fed Proc. 1984;43:2598-2602. [Medline] [Order article via Infotrieve]

3. Levy MN, Pappano AJ. Vagal control of myocardial contractility. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co Inc; 1994:241-259.

4. Sakmann B, Noma A, Trautwein W. Acetylcholine activation of single muscarinic K channels in isolated pacemaker cells of the mammalian heart. Nature. 1983;303:250-253. [Medline] [Order article via Infotrieve]

5. Brown AM. Coupling of G-proteins to cardiac ion channels. In: Levy MN, Schwartz PJ, eds. Vagal Control of the Heart: Experimental Basis and Clinical Implications. Armonk, NY: Futura Publishing Co Inc; 1994:133-146.

6. Kurachi Y, Tung RT, Ito H, Nakajima T. G protein activation of cardiac muscarinic K+ channels. Prog Neurobiol. 1992;39:229-246. [Medline] [Order article via Infotrieve]

7. Ito H, Tung RT, Sugimoto T, Kobayashi I, Takahashi K, Katada T, Ui M, Kurachi Y. On the mechanism of G protein ß gamma subunit activation of the muscarinic K+ channel in guinea pig atrial cell membrane. J Gen Physiol. 1992;99:961-983. [Abstract/Free Full Text]

8. Ito H, Vereecke J, Carmeliet E. Mode of regulation by G protein of the ATP-sensitive K+ channel in guinea-pig ventricular cell membrane. J Physiol (Lond). 1994;478:101-108. [Abstract/Free Full Text]

9. Wang YG, Lipsius SL. Acetylcholine potentiates acetylcholine-induced increases in K+ current in cat atrial myocytes. Am J Physiol. 1994;37:H1313-H1321.

10. Wang YG, Lipsius SL. Acetylcholine activates a glibenclamide-sensitive K+ current in cat atrial myocytes. Am J Physiol. 1995;37:H1322-H1334.

11. Zhou Z, Lipsius SL. Effect of isoprenaline on If current in latent pacemaker cells isolated from cat right atrium: ruptured vs perforated patch whole-cell recording methods. Pflugers Arch. 1993;423:442-447. [Medline] [Order article via Infotrieve]

12. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol. 1988;92:145-159. [Abstract/Free Full Text]

13. Wu J, Vereecke J, Carmeliet E, Lipsius SL. Ionic currents activated during hyperpolarization of single right atrial myocytes from cat heart. Circ Res. 1991;68:1059-1069. [Abstract/Free Full Text]

14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. [Medline] [Order article via Infotrieve]

15. Zhou Z, Lipsius SL. Properties of the pacemaker current (If) in latent pacemaker cells isolated from cat right atrium. J Physiol (Lond). 1992;453:503-523. [Abstract/Free Full Text]

16. Escande D. The pharmacology of ATP-sensitive K+ channels in the heart. Pflugers Arch. 1989;414:S93-S98.

17. Hamada E, Takikawa R, Ito H, Iguchi M, Terano A, Sugimoto T, Kurachi Y. Glibenclamide specifically blocks ATP-sensitive K+ channel current in atrial myocytes of guinea pig heart. Jpn J Physiol. 1990;54:473-477.

18. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983;305:147-148. [Medline] [Order article via Infotrieve]

19. Wilde AAM, Escande D, Schumacher CA, Thuringer D, Mestre M, Fiolet JWT, Janse MJ. Potassium accumulation in the globally ischemic mammalian heart. Circ Res. 1990;67:835-843. [Abstract/Free Full Text]

20. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca++ channels. Nature. 1983;303:535-537. [Medline] [Order article via Infotrieve]

21. Janczewski AM, Lakatta EG. Thapsigargin inhibits Ca2+ uptake, and Ca2+ depletes sarcoplasmic reticulum in intact cardiac myocytes. Am J Physiol. 1993;34:H517-H522.

22. Rousseau E, Smith JS, Meissner G. Ryanodine modifies conductance and gating behavior of single Ca2+ release channel. Am J Physiol. 1987;22:C364-C368.

23. Van Haastert PJM, Van Driel R, Jastorff B, Baraniak J, Stec WJ, De Wit RJW. Competitive cAMP antagonist for cAMP-receptor proteins. J Biol Chem. 1984;259:10020-10024. [Abstract/Free Full Text]

24. Ashkenazi A, Peralta EG. Muscarinic acetylcholine receptors. In: Peroutka SJ, ed. Handbook of Receptors and Channels: G-Protein Coupled Receptors. Boca Raton, Fla: CRC Press; 1994:1-27.

25. Ehlert FJ, Delen FM, Yun SH, Friedman DJ, Self DW. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart. J Pharmacol Exp Ther. 1989;251:660-671. [Abstract/Free Full Text]

26. Peralta EG, Ashkenazi A, Winslow JW, Ramachandran J, Capon DJ. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature. 1988;334:434-437. [Medline] [Order article via Infotrieve]

27. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548-553. [Medline] [Order article via Infotrieve]

28. Brown JH, Masters SB. Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart. Fed Proc. 1984;43:2613-2617. [Medline] [Order article via Infotrieve]

29. Vites A, Pappano A. Inositol 1,4,5-trisphosphate release intracellular Ca2+ in permeabilized chick atria. Am J Physiol. 1990;27:H1745-H1752.

30. Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res. 1994;74:299-309. [Abstract/Free Full Text]

31. Ehrlich BE, Kaftan E, Bezprozvannaya S, Bezprozvanny I. The pharmacology of intracellular Ca2+-release channels. Trends Pharmacol Sci. 1994;15:145-149. [Medline] [Order article via Infotrieve]

32. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science. 1993;262:740-744. [Abstract/Free Full Text]

33. Deutsch N, Weiss JN. ATP-sensitive K+ channel modification by metabolic inhibition in isolated guinea-pig ventricular myocytes. J Physiol (Lond). 1993;465:163-179. [Abstract/Free Full Text]

34. Brown SL, Brown JH. Muscarinic stimulation of phosphatidylinositol metabolism in atria. Mol Pharmacol. 1983;24:351-356. [Abstract]

35. Findlay I. Effects of ADP upon the ATP-sensitive K+ channel in rat ventricular myocytes. J Membr Biol. 1988;101:83-92. [Medline] [Order article via Infotrieve]

36. Tseng G-N, Hoffman BF. Actions of pinacidil on membrane currents in canine ventricular myocytes and their modulation by intracellular ATP and cAMP. Pflugers Arch. 1990;15:414-424.

37. Schackow TE, Ten Eick RE. Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by ß-adrenoreceptor stimulation. J Physiol (Lond). 1994;474:131-145. [Abstract/Free Full Text]

38. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 1991;30:H1675-H1686.

39. Wharton JM, Coleman RE, Strauss HC. The role of the autonomic nervous system in sudden cardiac death. Trends Cardiovasc Med. 1992;2:65-71.




This article has been cited by other articles:


Home page
J. Physiol.Home page
J. R. Ehrlich, T.-J. Cha, L. Zhang, D. Chartier, L. Villeneuve, T. E. Hebert, and S. Nattel
Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium
J. Physiol., June 1, 2004; 557(2): 583 - 597.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
Y. G. Wang, E. N. Dedkova, S. F. Steinberg, L. A. Blatter, and S. L. Lipsius
{beta}2-Adrenergic Receptor Signaling Acts via No Release to Mediate Ach-Induced Activation of Atp-Sensitive K+ Current in Cat Atrial Myocytes
J. Gen. Physiol., January 1, 2002; 119(1): 69 - 82.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
C. Mullner, D. Vorobiov, A. K. Bera, Y. Uezono, D. Yakubovich, B. Frohnwieser-Steinecker, N. Dascal, and W. Schreibmayer
Heterologous Facilitation of G Protein-Activated K+ Channels by {beta}-Adrenergic Stimulation via Camp-Dependent Protein Kinase
J. Gen. Physiol., May 1, 2000; 115(5): 547 - 558.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Carmeliet
Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias
Physiol Rev, July 1, 1999; 79(3): 917 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Babenko and G. Vassort
Enhancement of the ATP-Sensitive K+ Current by Extracellular ATP in Rat Ventricular Myocytes : Involvement of Adenylyl Cyclase–Induced Subsarcolemmal ATP Depletion
Circ. Res., April 19, 1997; 80(4): 589 - 600.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M.-C. Wellner-Kienitz, K. Bender, and L. Pott
Overexpression of beta 1 and beta 2 Adrenergic Receptors in Rat Atrial Myocytes. DIFFERENTIAL COUPLING TO G PROTEIN-GATED INWARD RECTIFIER K+ CHANNELS VIA Gs AND Gi/o
J. Biol. Chem., September 28, 2001; 276(40): 37347 - 37354.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y. G.
Right arrow Articles by Lipsius, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y. G.
Right arrow Articles by Lipsius, S. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL